Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lin, Minghua
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients	Recruiting	4	5000	RoW	Peginterferon Alfa-2B, Nucleoside Analogs	Third Affiliated Hospital, Sun Yat-Sen University	Hepatitis B, Chronic	12/26	11/29
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection	Completed	2	250	RoW	GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table	Sunshine Lake Pharma Co., Ltd.	Chronic HBV Infection	06/22	09/23

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lin, Minghua
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients	Recruiting	4	5000	RoW	Peginterferon Alfa-2B, Nucleoside Analogs	Third Affiliated Hospital, Sun Yat-Sen University	Hepatitis B, Chronic	12/26	11/29
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection	Completed	2	250	RoW	GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table	Sunshine Lake Pharma Co., Ltd.	Chronic HBV Infection	06/22	09/23